Spatial Organisation of Tumour cDC1 States Correlates with Effector and Stem‐Like CD8 + T Cells Location
European Journal of Immunology · 2025
DOI: 10.1002/eji.70011 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Cécile Piot und 13 weiteren Autor:innen. Beteiligte Einrichtung: Immunobiology Laboratory, The Francis Crick Institute, London, UK. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Dendritic Cells, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, European Research Council, Wellcome Trust.
Abstract (Originalsprache)
CD8 + T cells are central to targeting and eliminating cancer cells. Their function is critically supported by type 1 conventional dendritic cells (cDC1s), which both prime antigen‐specific CD8 + T cells in tumour‐draining lymph nodes (tdLNs) and sustain primed CD8 + T cells within tumours. Despite their importance, the spatiotemporal organisation of cDC1s within tumours and their diverse functional roles remain poorly understood. Here, we use scRNAseq and unbiased spatial analysis to construct a detailed map of cDC1 states and distribution within immunogenic mouse tumours during CD8 + T‐cell‐mediated rejection. We reveal two distinct cDC1 activation states characterised by differential expression of genes linked to anti‐tumour immunity, including Cxcl9 and Il12b . Strikingly, Il12b ‐expressing cDC1s are CCR7 + and enriched at tumour borders, where they closely associate with stem‐like TCF1 + CD8 + T cells. In contrast, CCR7 – Cxcl9 ‐expressing cDC1s are preferentially found within the tumour parenchyma alongside effector CD8 + T cells. Analysis of a published dataset of human tumours similarly reveals a spatial association between CCR7 + cDC1 and stem‐like TCF1 + CD8 + T cells. These findings uncover a highly spatially coordinated interaction between cDC1s and CD8 + T cells within tumours, shedding light on the intricate cellular dynamics that underpin effective anti‐tumour immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immunobiology Laboratory, The Francis Crick Institute, London, UK.
- Immunoregulation Laboratory, Champalimaud Research, Champalimaud Centre for the Unknown, Lisbon, Portugal.
- Division of Cancer Sciences, Faculty of Biology, Medicine and Health, The University of Manchester; and Advanced Immunotherapy and Cell Therapy Team, The Christie NHS Foundation Trust, Manchester, UK.
- Experimental Histopathology, The Francis Crick Institute, London, UK.
- Tumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.
- Medical Department, ADM Health & Wellness, London, UK.
ORCID-Profile: Adi Biram, Kok Haw Jonathan Lim
Förderung
- Medical Research Council
- European Research Council
- Wellcome Trust
- Cancer Research UK
- Louis-Jeantet Foundation
Zitieren
APA
Piot, C., Pereira da Costa, M., Biram, A., Minutti, C. M., Lim, K. H. J., Green, M., Mikolajczak, A., Jenkins, R. P., Meader, L., Buck, M. D., Cardoso, A., Rogers, N., Sahai, E., & Reis E Sousa, C. (2025). Spatial Organisation of Tumour cDC1 States Correlates with Effector and Stem‐Like CD8 + T Cells Location. European Journal of Immunology. https://doi.org/10.1002/eji.70011
Vancouver
Piot C, Pereira da Costa M, Biram A, Minutti CM, Lim KHJ, Green M, et al. Spatial Organisation of Tumour cDC1 States Correlates with Effector and Stem‐Like CD8 + T Cells Location. European Journal of Immunology. 2025. doi:10.1002/eji.70011
BibTeX
@article{Piot2025,
author = {Piot, Cécile and Pereira da Costa, Mariana and Biram, Adi and Minutti, Carlos M and Lim, Kok Haw Jonathan and Green, Mary and Mikolajczak, Ania and Jenkins, Robert P and Meader, Lucy and Buck, Michael D and Cardoso, Ana and Rogers, Neil and Sahai, Erik and Reis E Sousa, Caetano},
title = {Spatial Organisation of Tumour cDC1 States Correlates with Effector and Stem‐Like CD8 + T Cells Location},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.70011}
}
EUVIMED